Fazal Kabir | Nanotechnology Innovations | Best Researcher Award

Published on by Scientist Day

Global Scientist Day Awards

Fazal Kabir
Qilu Institute of Technology
Fazal Kabir
Affiliation Qilu Institute of Technology
Country China
Scopus ID 60720335800
Documents 1
Subject Area Nanotechnology Innovations
Event Global Scientist Day Awards

The Global Scientist Day Awards recognizes researchers whose scholarly work contributes to the advancement of science, technology, and innovation across diverse disciplines. Fazal Kabir, affiliated with Qilu Institute of Technology, has established an emerging academic profile within the field of Nanotechnology Innovations. Through scholarly publication and participation in scientific research, the researcher demonstrates an ongoing commitment to advancing knowledge in nanotechnology and related interdisciplinary domains. The available academic profile provides evidence of research activity documented through internationally recognized indexing services, supporting academic visibility and encouraging future scientific contributions.[1]

Abstract

Fazal Kabir is associated with Qilu Institute of Technology and contributes to research within the rapidly developing discipline of nanotechnology. Academic indexing through Scopus reflects participation in internationally recognized scientific publishing and provides an objective measure of scholarly activity. Research in nanotechnology supports innovation across engineering, materials science, healthcare, energy systems, and environmental applications.[1][2]

Introduction

Nanotechnology continues to transform multiple scientific disciplines by enabling the manipulation of materials at molecular and atomic scales. Research in this area contributes to advances in electronics, biomedical engineering, sustainable energy, environmental monitoring, and industrial manufacturing. Researchers working in nanotechnology help establish innovative approaches that improve performance, efficiency, and sustainability while expanding scientific understanding.[1]

Research Profile

Fazal Kabir is affiliated with Qilu Institute of Technology in China and has an indexed Scopus Author ID of 60720335800. The available Scopus record indicates one indexed scholarly document within the field of nanotechnology innovations. Although the publication portfolio remains in an early stage, inclusion within an internationally recognized citation database demonstrates participation in peer-reviewed scientific communication and contributes to the global exchange of research knowledge. [1]

Research Contributions

Research within nanotechnology frequently addresses the design, synthesis, characterization, and application of nanoscale materials capable of improving technological performance across numerous sectors. Even at an early stage of publication, scholarly participation contributes to cumulative scientific knowledge by supporting reproducibility, collaborative investigation, and future innovation. Academic dissemination through indexed journals enhances transparency and promotes international research accessibility.[2]

Research Impact

The scientific impact of emerging researchers extends beyond publication counts by fostering collaboration, introducing innovative methodologies, and expanding opportunities for interdisciplinary investigation. Early-career research provides valuable contributions that may support future advances in nanotechnology and its practical applications. Continued publication, international collaboration, and citation growth are expected to enhance academic influence while supporting technological innovation and scientific progress.[1][2]

Award Suitability

Based on the available academic profile, Fazal Kabir demonstrates active participation in internationally indexed scientific research and contributes to the expanding field of nanotechnology innovations. The research profile reflects engagement with peer-reviewed scholarly communication and illustrates commitment to scientific advancement through academic publication.[1]

Conclusion

Fazal Kabir represents an emerging researcher whose academic activities contribute to the advancement of nanotechnology research. Affiliation with Qilu Institute of Technology and inclusion within the Scopus database provide evidence of scholarly engagement and international academic visibility. Continued research productivity, publication, and collaboration have the potential to strengthen future scientific impact.[1]

References

  1. Elsevier (2026). Scopus author details: Fazal Kabir, Author ID 60720335800. Scopus.
    https://www.scopus.com/pages/authors/60720335800
  2. Exploring gadolinium-doped BaSrCa and Al-based ferrite nanoparticles for structural, mechanical, magnetic and radiation shielding applications.
    https://doi.org/10.1038/nnano.2015.79
  3. Global Scientist Day Awards (2026). Official Award Website.

    Global Scientist Day Awards


Fahad Sabei | Nanotechnology Innovations | Best Researcher Award

Published on by Scientist Day

Assoc. Prof. Dr. Fahad Sabei | Nanotechnology Innovations | Best Researcher Award

Assoc. Prof. Dr. Fahad Sabei | Jazan universe | Saudi Arabia

Dr. Fahad Y. Sabei is a distinguished academic and researcher serving as an Associate Professor at the College of Pharmacy, Jazan University, Saudi Arabia. With advanced training in pharmaceutical sciences from renowned institutions in the United States and Saudi Arabia, he has built a strong interdisciplinary background spanning molecular biology, drug formulation, and nanotechnology-focused cancer therapeutics. Dr. Sabei’s expertise centers on the design and development of polymeric nanoparticles for both imaging and targeted treatment applications. His work integrates cutting-edge molecular techniques with innovative drug-delivery systems, contributing to advancements in cancer diagnosis and therapy. He is proficient in a wide spectrum of laboratory and research methodologies, including PCR, qPCR, RNA extraction, cell culture, and animal cancer models, complemented by experience with imaging tools such as ultrasound, photoacoustic systems, and Pearl imaging platforms. His technical capabilities are supported by strong data analysis and visualization skills using software such as GraphPad Prism and ChemBioDraw. At Jazan University, Dr. Sabei plays a key role in academic development, student mentoring, and research supervision. He has been an active contributor to institutional committees, including academic affairs, performance indicators, quality initiatives, community service, SPLE committee activities, and ward committee responsibilities. His leadership extends beyond teaching, encompassing student support, program enhancement, and strengthening research culture within the college. Dr. Sabei has participated in prominent scientific conferences and professional forums across the Middle East and the United States, presenting research in pharmaceutical sciences, nanomedicine, and drug-delivery innovations. His work has also been supported by multiple stages of institutional research funding, reflecting the significance and impact of his contributions. With a commitment to scientific innovation, health advancement, and community engagement, Dr. Fahad Y. Sabei continues to influence the future of pharmaceutical sciences and contribute meaningfully to the progression of medical research in Saudi Arabia and beyond.

Profile: Orcid

Featured Publications

Bakkari, M. A., Ghoal, G., Sabei, F. Y., Safhi, A. Y., & Moni, S. S. (2025). Exploring Interleukin-6 inhibitor antibodies in combatting SARS-CoV-2 and its mutated variants: Challenges and future directions. Journal of Pharmacology and Pharmacotherapeutics. https://doi.org/10.1177/0976500X251316939

Fatima, I., Safhi, A. Y., Alsalhi, A., Hanbashi, A., Jali, A., Alsabei, H. M., Alshabrmi, F. M., & Sabei, F. Y. (2025). Identification and validation of key covalent inhibitors targeting lung cancer proteins through integrated in silico analysis. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152973

Madkhali, O. A., Moni, S. S., Almoshari, Y., Sabei, F. Y., & Safhi, A. Y. (2025). Dual role of CXCL10 in cancer progression: Implications for immunotherapy and targeted treatment. Cancer Biology & Therapy. https://doi.org/10.1080/15384047.2025.2538962

Akhtar, S., Shafeeq, S., Siddique, A. B., Sabei, F. Y., Safhi, A. Y., Ullah, S., Abbas, A., Hanbashi, A., Alshahi, H., Jali, A. M., et al. (2025). Facile synthesis of bimetallic Ag-Fe core–shell nanoparticles for the selective and efficient dehydrogenation of formic acid. Journal of Power Sources. https://doi.org/10.1016/j.jpowsour.2025.236919

Zoghebi, K., Sabei, F. Y., & Safhi, A. Y. (2024). Exploring the anti-cancer properties of Carissa carandas as a multi-targeted approach against breast cancer. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2024.2437548

Shakir, R., Hanif, S., Salawi, A., Arshad, R., Sarfraz, R. M., Irfan, M., Raza, S. A., Barkat, K., Sabei, F. Y., Almoshari, Y., et al. (2024). Correction: Shakir et al. Exorbitant drug loading of metformin and sitagliptin in mucoadhesive buccal tablet: In vitro and in vivo characterization in healthy volunteers (2022). Pharmaceuticals. https://doi.org/10.3390/ph17050556